NCT01318525 - Efficacy & Safety of ALF-5755 in Patients With Nonacetaminophen Severe Acute Hepatitis & Early Stage Acute Liver Failure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

May 31, 2012

Study Completion Date

September 30, 2012

Conditions

Liver Failure, Acute

Interventions

DRUG

ALF-5755

10 mg (25 ml) given in slow intravenous infusion over 10 minutes with an automatic syringe

DRUG

Saline solution (0.9% NaCl)

25 ml given in slow intravenous infusion over 10 minutes with an automatic syringe

Trial Locations (12)

13385

NOT_YET_RECRUITING

Hôpital Conception, Marseille

25030

NOT_YET_RECRUITING

CHU de Besançon, Besançon

34295

RECRUITING

Hôpital Saint-Eloi, Montpellier

38043

RECRUITING

CHU de Grenoble, Grenoble

59037

NOT_YET_RECRUITING

Hôpital Claude Huriez, Lille

63003

NOT_YET_RECRUITING

CHU Clermont-Ferrand, Clermont-Ferrand

69004

RECRUITING

Hôpital Croix-Rousse, Lyon

75571

RECRUITING

Hôpital Saint Antoine, Paris

75651

RECRUITING

Hôpital La Pitié Salpétrière, Paris

92110

RECRUITING

Hôpital Beaujon, Clichy

94804

RECRUITING

Centre Hépatobiliaire Paul Brousse, Villejuif

06202

NOT_YET_RECRUITING

Hôpital de l'Archet 2, Nice